Susceptibility of clinical isolates of Candida to photodynamic effects of curcumin

Lasers in Surgery and Medicine

Volumn 43, Issue 9, 2011, Pages 927-934

  Dovigo, Lívia N ^a   Pavarina, Ana C ^a   Carmello, Juliana C ^a   MacHado, Ana L ^a   Brunetti, Iguatemy L ^a   Bagnato, Vanderlei S ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Candida albicans; Candida glabrata; Candida tropicalis; photodynamic therapy; turmeric

Indexed keywords

CRYSTAL VIOLET; CURCUMIN;

ANALYSIS OF VARIANCE; ARTICLE; BIOFILM; BIOMASS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; DRUG SENSITIVITY; FUNGUS ISOLATION; KRUSKAL WALLIS TEST; METABOLISM; NONHUMAN; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PLANKTON; PRIORITY JOURNAL; STAINING; WILCOXON SIGNED RANKS TEST;

BIOFILMS; CANDIDA; CURCUMIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PHOTOCHEMOTHERAPY; PLANKTON;

EID: 80055008024     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21110     Document Type: Article

References (43)

1. Odds FC, editor. Candida and candidosis: A review and bibliography. London: Bailliere Tindall; 1988.
2. Ribeiro DG, Pavarina AC, Dovigo LN, de Oliveira Mima EG, Machado AL, Bagnato VS, Vergani CE,. Photodynamic inactivation of microorganisms present on complete dentures. A clinical investigation. Lasers Med Sci 2011; in press.
3. Cannon RD, Holmes AR, Mason AB, Monk BC,. Oral Candida: Clearance, colonization, or candidiasis? J Dent Res 1995; 74: 1152-1161.
4. Samaranayake LP,. Host factors and oral candidosis. In:, Samaranayake LP, MacFarlane TW, editors. Oral candidosis. London: Butterworth; 1990. pp 66-103.
5. Scully C, El-Kabir M, Samaranayake LP,. Candida and oral candidosis: A review. Crit Rev Oral Biol Med 1994; 5: 125-157.
6. Krcmery V, Barnes AJ,. Non-albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243-260.
7. Wingard JR,. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115-125.
8. Dahiya MC, Redding SW, Dahiya RS, Eng TY, Kirkpatrick WR, Coco BJ, Sadkowski LC, Fothergill AW, Waite A, Rinaldi MG, Patterson TF, Thomas CR,. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003; 57: 79-83.
9. Perezous LF, Flaitz CM, Goldschmidt ME, Engelmeier RL,. Colonization of Candida species in denture wearers with emphasis on HIV infection: A literature review. J Prosthet Dent 2005; 93: 288-293.
10. Pfaller MA, Rhine-Chalberg J, Redding SW, Smith J, Farinacci G, Fothergill AW, Rinaldi MG,. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994; 32: 59-64.
11. Seneviratne CJ, Silva WJ, Samaranayake YH, Samaranayake LP,. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata. Arch Oral Biol 2009; 54: 1052-1060.
12. Hamblin MR, Hasan T,. Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem Photobiol Sci 2004; 3: 436-450.
13. Donnelly RF, McCarron PA, Tunney MM,. Antifungal photodynamic therapy. Microbiol Res 2008; 163: 1-12.
14. Bliss JM, Bigelow CE, Foster TH, Haidaris CG,. Susceptibility of Candida species to photodynamic effects of Photofrin. Antimicrob Agents Chemother 2004; 48: 2000-2006.
15. Dovigo LN, Pavarina AC, Mima EG, Giampaolo ET, Vergani CE, Bagnato VS,. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses 2011; 54: 123-130.
16. Paardekooper M, Van den Broek PJ, De Bruijne AW, Elferink JG, Dubbelman TM, Van Steveninck J,. Photodynamic treatment of yeast cells with the dye toluidine blue: All-or-none loss of plasma membrane barrier properties. Biochim Biophys Acta 1992; 1108: 86-90.
17. Zeina B, Greenman J, Purcell WM, Das B,. Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol 2001; 144: 274-278.
18. Strackhovskaya MG, Belenikina NS, Ivanova EV, Chemeris YK, Stranadko EF,. The photodynamic inactivation of the yeast Candida guilliermondii in the presence of photodithazine. Microbiology 2002; 71: 345-348.
19. Copley L, van der Watt P, Wirtz KW, Parker MI, Leaner VD,. Photolon, a chlorin e6 derivative, triggers ROS production and light-dependent cell death via necrosis. Int J Biochem Cell Biol 2008; 40: 227-235.
20. Mantareva V, Kussovski V, Angelov I, Wöhrle D, Dimitrov R, Popova E, Dimitrov S,. Non-aggregated Ga(III)-phthalocyanines in the photodynamic inactivation of planktonic and biofilm cultures of pathogenic microorganisms. Photochem Photobiol Sci 2011; 10: 91-102.
21. Mima EG, Pavarina AC, Dovigo LN, Vergani CE, Costa CA, Kurachi C, Bagnato VS,. Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 392-401.
22. Epstein J, Sanderson IR, Macdonald TT,. Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies. Br J Nutr 2010; 103: 1545-1557.
23. Dovigo LN, Pavarina AC, Ribeiro AP, Brunetti IL, Costa CA, Jacomassi DP, Bagnato VS, Kurachi C,. Investigation of the photodynamic effects of curcumin against Candida albicans. Photochem Photobiol 2011; in press.
24. Dahl TA, Bilski P, Reszka KJ, Chignell CF,. Photocytotoxicity of curcumin. Photochem Photobiol 1994; 59: 290-294.
25. Chignell CF, Bilski P, Reszka KJ, Motten AG, Sik RH, Dahl TA,. Spectral and photochemical properties of curcumin. Photochem Photobiol 1994; 59: 295-302.
26. Haukvik T, Bruzell E, Kristensen S, Tønnesen HH,. Photokilling of bacteria by curcumin in different aqueous preparations. Studies on curcumin and curcuminoids XXXVI. Pharmazie 2009; 64: 666-673.
27. Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP,. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 2003; 41: 2961-2967.
28. Melo AS, Colombo AL, Arthington-Skaggs BA,. Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species. Antimicrob Agents Chemother 2007; 51: 3081-3088.
29. Martins CV, da Silva DL, Neres AT, Magalhães TF, Watanabe GA, Modolo LV, Sabino AA, de Fátima A, de Resende MA,. Curcumin as a promising antifungal of clinical interest. J Antimicrob Chemother 2009; 63: 337-339.
30. Sharma M, Manoharlal R, Puri N, Prasad R,. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. Biosci Rep 2010; 30: 391-404.
31. Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, Dei D, Fantetti L, Chiti G, Roncucci G,. Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers Surg Med 2006; 38: 468-481.
32. Garcia-Gomes AS, Curvelo JA, Soares RM, Ferreira-Pereira A,. Curcumin acts synergistically with fluconazole to sensitize a clinical isolate of Candida albicans showing a MDR phenotype. Med Mycol 2011; in press.
33. Neelofar K, Shreaz S, Rimple B, Muralidhar S, Nikhat M, Khan LA,. Curcumin as a promising anticandidal of clinical interest. Can J Microbiol 2011; 57: 204-210.
34. Dahl TA, McGowan WM, Shand MA, Srinivasan VS,. Photokilling of bacteria by the natural dye curcumin. Arch Microbiol 1989; 151: 183-185.
35. Tønnesen HH, de Vries H, Karlsen J, Beijersbergen van Henegouwen G,. Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems. J Pharm Sci 1987; 76: 371-373.
36. Kassab NH, Mustafa EA, Al-Saffar MT,. The ability of different curcumine solutions on reducing Candida albicans biofilm activity on acrylic resin denture base material. Al-Rafidain Dent J 2007; 7: 32-37.
37. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA,. Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-5394.
38. Bizerra FC, Nakamura CV, de Poersch C, Estivalet Svidzinski TI, Borsato Quesada RM, Goldenberg S, Krieger MA, Yamada-Ogatta SF, Lambrechts SA, Aalders MC, Verbraak FD, Lagerberg JW, Dankert JB, Schuitmaker JJ,. Characteristics of biofilm formation by Candida tropicalis and antifungal resistance. FEMS Yeast Res 2008; 8: 442-450.
39. Lambrechts SA, Aalders MC, Verbraak FD, Lagerberg JW, Dankert JB, Schuitmaker JJ,. Effect of albumin on the photodynamic inactivation of microorganisms by a cationic porphyrin. J Photochem Photobiol B 2005; 79: 51-57.
40. Priyadarsini KI,. Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol C 2009; 10: 81-95.
41. Collins TL, Markus EA, Hassett DJ, Robinson JB,. The effect of a cationic porphyrin on Pseudomonas aeruginosa biofilms. Curr Microbiol 2010; 61: 411-416.
42. Goulart R de C, Bolean M, Paulino T de P, Thedei G Jr, Souza SL, Tedesco AC, Ciancaglini P,. Photodynamic therapy in planktonic and biofilm cultures of Aggregatibacter actinomycetemcomitans. Photomed Laser Surg 2010; 28: S53-S60.
43. Pereira CA, Romeiro RL, Costa AC, Machado AK, Junqueira JC, Jorge AO,. Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: An in vitro study. Lasers Med Sci 2011; 26: 341-348.